SCHEMBL26423280

SCHEMBL26423280

c1cnc2c(c1)oc1cc3ccncc3cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 2/20 0.39
GRM4 Q14833 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
HASPIN Q8TF76 11/20 0.38
PIM1 P11309 4/20 0.37
CCNT1 O60563 3/20 0.37
CDK9 P50750 3/20 0.37
MAPK14 Q16539 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
DYRK1A Q13627 1/20 0.36
IMPDH2 P12268 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
IKBKB O14920 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423208 0.85 ALDH1A1 (0.42) GRM4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL26423359 0.82 HASPIN (0.40) CLK1GRM4HASPINPIM1CCNT1
SCHEMBL26423357 0.82 HASPIN (0.40) CLK1GRM4HASPINPIM1CCNT1
SCHEMBL26423242 0.80 KDM4E (0.44) CLK1GRM4HASPINPIM1CCNT1
SCHEMBL26423245 0.80 KDM4E (0.44) CLK1GRM4HASPINPIM1CCNT1
SCHEMBL17756864 0.80 CLK1 (0.49) CLK1GRM4HASPINPIM1CCNT1
SCHEMBL26423191 0.80 CLK1 (0.49) CLK1GRM4HASPINPIM1CCNT1
SCHEMBL26423401 0.79 EGFR (0.38) GRM4MAPK14IMPDH2KDM4ENPC1
SCHEMBL26423374 0.79 EGFR (0.38) GRM4MAPK14IMPDH2KDM4ENPC1
SCHEMBL11885009 0.79 MAPK14 (0.42) GRM4CYP3A4CYP2D6MAPK14KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 CLK1 4489/4885GRM4 2835/4885CYP1A2 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.